Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Fentanyl for Abscess Incision and Drainage
NCT03872700Phase 3Completed
- Sponsor
- Montefiore Medical Center
- Start
- Aug 2019
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fentanyl citrate nasal spray in procedural pain (2 arms), sponsored by Montefiore Medical Center. Primary endpoints: Numerical Rating Scale Pain Score at Baseline, Numerical Rating Scale Pain Score After Lidocaine Injection up to 12 minutes and 5 more. Started Aug 2019; status: completed.
02
Drugs
fentanyl citrate nasal spray
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT03872700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03872700.